全文获取类型
收费全文 | 27208篇 |
免费 | 1900篇 |
国内免费 | 89篇 |
专业分类
耳鼻咽喉 | 235篇 |
儿科学 | 833篇 |
妇产科学 | 635篇 |
基础医学 | 4142篇 |
口腔科学 | 572篇 |
临床医学 | 2792篇 |
内科学 | 5457篇 |
皮肤病学 | 531篇 |
神经病学 | 2836篇 |
特种医学 | 843篇 |
外国民族医学 | 4篇 |
外科学 | 2514篇 |
综合类 | 188篇 |
一般理论 | 27篇 |
预防医学 | 2801篇 |
眼科学 | 575篇 |
药学 | 1787篇 |
中国医学 | 43篇 |
肿瘤学 | 2382篇 |
出版年
2023年 | 204篇 |
2022年 | 370篇 |
2021年 | 695篇 |
2020年 | 465篇 |
2019年 | 667篇 |
2018年 | 754篇 |
2017年 | 582篇 |
2016年 | 679篇 |
2015年 | 769篇 |
2014年 | 967篇 |
2013年 | 1355篇 |
2012年 | 1958篇 |
2011年 | 1975篇 |
2010年 | 1104篇 |
2009年 | 991篇 |
2008年 | 1729篇 |
2007年 | 1687篇 |
2006年 | 1521篇 |
2005年 | 1503篇 |
2004年 | 1307篇 |
2003年 | 1352篇 |
2002年 | 1168篇 |
2001年 | 357篇 |
2000年 | 282篇 |
1999年 | 292篇 |
1998年 | 249篇 |
1997年 | 196篇 |
1996年 | 175篇 |
1995年 | 165篇 |
1994年 | 169篇 |
1993年 | 150篇 |
1992年 | 188篇 |
1991年 | 215篇 |
1990年 | 204篇 |
1989年 | 209篇 |
1988年 | 160篇 |
1987年 | 152篇 |
1986年 | 159篇 |
1985年 | 158篇 |
1984年 | 151篇 |
1983年 | 104篇 |
1982年 | 109篇 |
1981年 | 92篇 |
1980年 | 86篇 |
1979年 | 112篇 |
1978年 | 105篇 |
1977年 | 79篇 |
1974年 | 88篇 |
1973年 | 90篇 |
1972年 | 83篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
11.
12.
13.
Five agents are currently approved for the treatment of chronic hepatitis B infection. This article will discuss the three agents for which the most extensive data are available; interferon (IFN), lamivudine, and adefovir, while the following article by Dr. Jules Dienstag will discuss the recently marketed agents, entecavir and peginterferon alfa-2a. The advantages of IFN are its finite duration of therapy (4–6 months), lack of emergence of resistance, and durability of response. On the negative side, response to IFN is less durable in patients with HBeAg-negative chronic hepatitis B virus (HBV). Also, use of IFN is limited by adverse effects and the mode of administration (daily to thrice-weekly subcutaneous injection). Lamivudine and adefovir are orally administered and have good tolerability and safety. Even in patients who experience a marked decrease in serum HBV DNA and loss of HBeAg, oral therapy needs to be continued for at least 6 months, to avoid the risk of reappearance of HBeAg and viremia. Rates of HBeAg seroconversion to anti-HBe-positivity increase with duration of lamivudine or adefovir therapy. The likelihood of development of resistance to lamivudine and associated viral breakthrough limits its long-term use. In patients with HBeAg-negative chronic hepatitis B, long-term therapy is usually required, as off-treatment relapse is common. The emergence of resistance to adefovir is delayed and infrequent, hence adefovir may be preferred in patients requiring long-term therapy. 相似文献
14.
15.
Nonconvulsive status epilepticus may be subdivided into generalized (absence) status and complex partial status. The latter is regarded as a rarity, whereas the former constitutes the dominant part of the hitherto reported cases. We report 10 consecutive cases of adult patients with nonconvulsive status epilepticus, all documented by ictal electroencephalographic (EEG) recordings. Five had a complex partial status; the origin of the complex partial status appeared to be frontal in four of these patients. Three had recurrent complex partial seizures with incomplete recovery between seizures, and two had more continuous symptoms. One of the latter exhibited neither motor phenomena nor automatisms. The effect of diazepam or clonazepam was immediate in all 10 cases though transient in eight. A lasting control of the status was not achieved in six patients until i.v. phenytoin was added. The difficulties in the differentiation between complex partial status and absence status despite ictal EEG recordings are discussed, illustrated by a case with seizure discharges of a focal onset which rapidly generalized. The study indicates that complex partial status may be more common and the clinical expressions of absence status more variable than hitherto recognized. 相似文献
16.
Ophira Salomon Joseph Moisseiev Tamara Vilganski Rima Dardik Shimon Kurtz Eva Shpringer David M Steinberg Nurit Rosenberg 《Blood coagulation & fibrinolysis》2006,17(6):485-488
To determine whether polymorphisms of platelet surface glycoprotein associated with arterial thrombosis are risk factors for branch retinal vein occlusion. A case-control study in which 69 patients with branch retinal vein occlusion and 147 controls who attended the eye clinic for nonvascular complications participated. DNA was extracted from whole blood and analyzed for genotyping of platelet glycoprotein polymorphisms by polymerase chain reactions and specific restricted enzymes. No relationship was found between the four platelet glycoprotein polymorphisms i.e. GPIa C807T, VNTR and Kozak of glycoprotein Ibalpha, the HPA-1 of glycoprotein IIIa and the occurrence of branch retinal vein occlusion. The HPA-2 polymorphism was found in 18 out 60 (30%) patients with branch retinal vein occlusion in comparison with 27 out 142 (19%) of controls, with an estimated odds ratio of 1.8 (95% confidence interval, 0.91-3.65). The four platelet glycoprotein polymorphisms are not risk factors for branch retinal vein occlusion and therefore it seems unnecessary to screen those patients for it. A larger study is required, however, to determine whether HPA-2 is a novel risk factor for branch retinal vein occlusion. 相似文献
17.
18.
Rebecca Voltan Arianna Castaldello Egidio Brocca-Cofano Rita De Michele Chiara Triulzi Giuseppe Altavilla Luisa Tondelli Michele Laus Katia Sparnacci Eva Reali Riccardo Gavioli Barbara Ensoli Antonella Caputo 《Vaccine》2009
Cationic block copolymers spontaneously assemble via electrostatic interactions with DNA molecules in aqueous solution giving rise to micellar structures that protect the DNA from enzymatic degradation both in vitro and in vivo. In addition, we have previously shown that they are safe, not immunogenic and greatly increased antigen-specific CTL responses following six intramuscular inoculations of a very low dose (1 μg) of the vaccine DNA as compared to naked DNA. Nevertheless, they failed to elicit detectable humoral responses against the antigen. To gain further insight in the potential application of this technology, here we show that a shorter immunization protocol based on two DNA intramuscular inoculations of 1 μg of DNA delivered by these copolymers and a protein boost elicits in mice broad (both humoral and cellular) and long-lasting responses and increases the antigen-specific Th1-type T cell responses and CTLs as compared to priming with naked DNA. These results indicate that cationic block copolymers represent a promising adjuvant and delivery technology for DNA vaccination strategies aimed at combating intracellular pathogens. 相似文献
19.
Immunoglobulin M Enzyme-Linked Immunosorbent Assay Using Recombinant Polypeptides for Diagnosis of Dengue 下载免费PDF全文
Elsa Videa Maria Josefina Coloma Flavia Barreto dos Santos Angel Balmaseda Eva Harris 《Clinical and Vaccine Immunology : CVI》2005,12(7):882-884
We demonstrate that a mixture of four recombinant dengue virus E polypeptides corresponding to the N-terminal region of the envelope protein from all serotypes substitutes for standard antigens in two immunoglobulin M enzyme-linked immunosorbent assay formats with 100% concordance, making these polypeptides a useful and accessible reagent for serological diagnosis of dengue in endemic countries. 相似文献
20.